PL2340809T3 - Lek zawierający fluorochinoliny - Google Patents

Lek zawierający fluorochinoliny

Info

Publication number
PL2340809T3
PL2340809T3 PL11151745T PL11151745T PL2340809T3 PL 2340809 T3 PL2340809 T3 PL 2340809T3 PL 11151745 T PL11151745 T PL 11151745T PL 11151745 T PL11151745 T PL 11151745T PL 2340809 T3 PL2340809 T3 PL 2340809T3
Authority
PL
Poland
Prior art keywords
medicament containing
containing fluoroquinolones
fluoroquinolones
medicament
Prior art date
Application number
PL11151745T
Other languages
English (en)
Inventor
Iris Heep
Kristine Fraatz
Hans-Jürgen Hamann
Markus Edingloh
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38171208&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2340809(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of PL2340809T3 publication Critical patent/PL2340809T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL11151745T 2006-03-08 2007-02-23 Lek zawierający fluorochinoliny PL2340809T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006010643A DE102006010643A1 (de) 2006-03-08 2006-03-08 Arzneimittel enthaltend Fluorchinolone
EP07846476A EP1993510A1 (de) 2006-03-08 2007-02-23 Arzneimittel enthaltend fluorchinolone
EP11151745.4A EP2340809B1 (de) 2006-03-08 2007-02-23 Arzneimittel enthaltend Fluorchinolone

Publications (1)

Publication Number Publication Date
PL2340809T3 true PL2340809T3 (pl) 2015-09-30

Family

ID=38171208

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11151745T PL2340809T3 (pl) 2006-03-08 2007-02-23 Lek zawierający fluorochinoliny

Country Status (31)

Country Link
US (1) US10231925B2 (pl)
EP (2) EP2340809B1 (pl)
JP (1) JP5584418B2 (pl)
KR (2) KR20080106253A (pl)
CN (2) CN101394836B (pl)
AR (1) AR059696A1 (pl)
AU (1) AU2007291622B2 (pl)
BR (1) BRPI0708613B1 (pl)
CA (1) CA2645037C (pl)
CR (1) CR10270A (pl)
DE (1) DE102006010643A1 (pl)
DK (1) DK2340809T3 (pl)
EC (1) ECSP088716A (pl)
ES (1) ES2542206T3 (pl)
GT (1) GT200800173A (pl)
HU (1) HUE025044T2 (pl)
IL (1) IL193429A0 (pl)
MX (1) MX2008011344A (pl)
MY (1) MY152885A (pl)
NZ (1) NZ571046A (pl)
PE (1) PE20071021A1 (pl)
PL (1) PL2340809T3 (pl)
PT (1) PT2340809E (pl)
RU (1) RU2527327C2 (pl)
SI (1) SI2340809T1 (pl)
SV (1) SV2008003014A (pl)
TW (1) TWI494105B (pl)
UA (1) UA96753C2 (pl)
UY (1) UY30191A1 (pl)
WO (1) WO2008025380A1 (pl)
ZA (1) ZA200807484B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1405890B2 (en) 2001-05-15 2017-03-15 Eurokera Thermochromic material
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2010069493A1 (de) * 2008-12-18 2010-06-24 Bayer Animal Health Gmbh Verbesserte wirkstoffkombination enthaltend ein antibiotikum und einen nichtsteroidalen entzündungshemmer (nsaid)
EP2332916A3 (en) 2009-11-19 2011-08-03 Krka Tovarna Zdravil, D.D., Novo Mesto A process for a preparation of marbofloxacin and intermediate thereof
CN101716141B (zh) * 2010-01-20 2011-11-30 白求恩医科大学制药厂 一种氟罗沙星注射液及其制备方法
GB2480276A (en) * 2010-05-11 2011-11-16 Michael Hilary Burke Process for the preparation of an aqueous injectable enrofloxacin antimicrobial formulation
RU2682171C2 (ru) * 2016-10-11 2019-03-15 Закрытое Акционерное Общество "Биологические Исследования И Системы" (Зао "Бис") Фармацевтическая комбинированная композиция для лечения гнойных ран на основе фторхинолонов (варианты)
EP3534708A1 (en) * 2016-11-07 2019-09-11 Jubilant Life Sciences Limited Synergistic antimicrobial compositions
WO2018146194A1 (en) * 2017-02-13 2018-08-16 Bayer Animal Health Gmbh Liquid composition containing pradofloxacin
WO2019023842A1 (en) 2017-07-31 2019-02-07 Dow Silicones Corporation MOISTURE CURING COMPOSITIONS
JP7576978B2 (ja) 2017-07-31 2024-11-01 ダウ シリコーンズ コーポレーション 湿分硬化性組成物
CN111620901B (zh) * 2020-06-08 2023-03-21 蚌埠医学院第二附属医院 一种含硅氧烷基的氟喹诺酮化合物、其制备方法及用途
CN118294548A (zh) * 2022-12-29 2024-07-05 瑞普（天津）生物药业有限公司 一种普拉沙星有关物质的检测方法及其应用
CN119504580A (zh) * 2024-11-25 2025-02-25 华南农业大学 一种二氟沙星及其盐基化合物的晶体及其制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4472405A (en) 1982-11-12 1984-09-18 Riker Laboratories, Inc. Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives
US4730000A (en) 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
AT392789B (de) 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
IN166416B (pl) 1985-09-18 1990-05-05 Pfizer
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
DE3831514A1 (de) 1988-09-16 1990-03-22 Bayer Ag Ph-neutrale waessrige loesungen von chinoloncarbonsaeuren
US5225413A (en) 1988-09-16 1993-07-06 Bayer-Aktiengesellschaft pH-neutral aqueous solutions of quinolone-carboxylic acids
JP2832535B2 (ja) 1989-04-04 1998-12-09 富山化学工業株式会社 キノロンカルボン酸またはその塩の可溶化法
WO1991009616A1 (en) 1989-12-22 1991-07-11 Yale University Quinolone antibiotics encapsulated in lipid vesicles
AU647772B2 (en) 1989-12-29 1994-03-31 Abbott Laboratories Quinolone carboxylic acid--metal ion--acid complexes
FR2665635A1 (fr) 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
DE69224071T2 (de) 1991-09-17 1998-05-07 Alcon Lab Inc Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
ATE212551T1 (de) 1995-12-21 2002-02-15 Pfizer Injizierbare quinolonformulierungen
EP0882049B1 (de) 1996-02-23 2002-11-20 Bayer Ag Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate
EP0974364A4 (en) 1996-10-25 2000-12-20 Yoshitomi Pharmaceutical METHOD FOR PREVENTING THE PREPARATION OF MEDICINAL PRODUCTS
GB9714218D0 (en) 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
DE19729879C2 (de) * 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
ES2321042T3 (es) * 1997-09-15 2009-06-01 THE PROCTER & GAMBLE COMPANY Quinolonas antimicrobianas, composiciones y usos de las mismas.
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
US6605751B1 (en) 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
ID21415A (id) * 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
DE19918324A1 (de) 1999-04-22 2000-10-26 Mann Gerhard Chem Pharm Fab Pharmazeutische Zusammensetzung wirksam gegen durch Bakterien, Viren, Pilze, Hefen und Protozoen verursachte Krankheitszustände
US6482799B1 (en) 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
DE19937115A1 (de) 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
EP1214056B1 (en) * 1999-09-24 2003-10-29 Alcon Inc. Topical suspension formulations containing ciprofloxacin and dexamethasone
MXPA05008913A (es) * 2003-02-21 2005-10-05 Sun Pharmaceutical Ind Ltd Formulacion oftalmica estable que contiene antibiotico y corticoesteroide.
DE10312346A1 (de) 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
RU2248199C1 (ru) * 2003-06-02 2005-03-20 Открытое Акционерное Общество "Акционерное Курганское общество медицинских препаратов и изделий "Синтез" (ОАО "Синтез") Глазные капли и способ их получения
DE10337191A1 (de) 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102004015981A1 (de) 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
PL1776109T3 (pl) * 2004-08-13 2009-06-30 Schering Plough Ltd Farmaceutyczna formulacja zawierająca antybiotyk, triazol i kortykosteroid

Also Published As

Publication number Publication date
WO2008025380A1 (de) 2008-03-06
SI2340809T1 (sl) 2015-08-31
DK2340809T3 (en) 2015-07-20
AU2007291622A1 (en) 2008-03-06
AR059696A1 (es) 2008-04-23
SV2008003014A (es) 2010-05-17
CN101394836B (zh) 2017-08-29
EP2340809A3 (de) 2012-09-19
HUE025044T2 (en) 2016-01-28
EP1993510A1 (de) 2008-11-26
KR20150046367A (ko) 2015-04-29
EP2340809B1 (de) 2015-04-15
TW200810756A (en) 2008-03-01
CN101394836A (zh) 2009-03-25
GT200800173A (es) 2009-09-14
MX2008011344A (es) 2008-11-12
KR20080106253A (ko) 2008-12-04
JP2009529015A (ja) 2009-08-13
US20100009979A1 (en) 2010-01-14
BRPI0708613B1 (pt) 2021-10-19
CA2645037C (en) 2016-06-28
DE102006010643A1 (de) 2007-09-13
EP2340809A2 (de) 2011-07-06
NZ571046A (en) 2012-05-25
BRPI0708613A2 (pt) 2011-06-07
AU2007291622B2 (en) 2013-08-01
TWI494105B (zh) 2015-08-01
US10231925B2 (en) 2019-03-19
JP5584418B2 (ja) 2014-09-03
ZA200807484B (en) 2009-11-25
ECSP088716A (es) 2008-11-27
CR10270A (es) 2009-03-18
UA96753C2 (ru) 2011-12-12
CA2645037A1 (en) 2008-03-06
ES2542206T3 (es) 2015-08-03
MY152885A (en) 2014-11-28
UY30191A1 (es) 2007-10-31
PE20071021A1 (es) 2007-11-25
RU2008139635A (ru) 2010-04-20
IL193429A0 (en) 2009-05-04
PT2340809E (pt) 2015-08-28
CN104208064A (zh) 2014-12-17
RU2527327C2 (ru) 2014-08-27

Similar Documents

Publication Publication Date Title
SI2340809T1 (sl) Zdravilo, ki vsebuje fluorokinolone
GB2453483B (en) Medication dispenser
IL194762A0 (en) Pharmaceutical compounds
ZA200809479B (en) New pharmaceutical compounds
GB0608820D0 (en) Pharmaceutical compounds
GB0712389D0 (en) A Pharmaceutical composition
GB0600070D0 (en) Dose counter
GB0625783D0 (en) Medicament
GB0608176D0 (en) Pharmaceutical Compounds
GB0613031D0 (en) Medicaments
GB0608184D0 (en) Pharmaceutical compounds
GB0615064D0 (en) Medicament
GB0600168D0 (en) A therapeutic composition
GB0608996D0 (en) Drug counter
GB0608175D0 (en) Pharmaceutical Compounds
GB0608264D0 (en) Pharmaceutical compounds
TWM292546U (en) Medicament counter
GB0615814D0 (en) Medicament
ZA200708369B (en) Medicament
GB0625682D0 (en) Pharmaceutical compounds
GB0622892D0 (en) Pharmaceutical compounds
GB0622268D0 (en) A medicament
GB0608269D0 (en) Therapeutic compounds
GB0623402D0 (en) Medicament dispenser
GB0722047D0 (en) A medicament